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ABSTRACT 
            Prostate cancer is now the second leading cause of cancer death in American men. 
Since many of the diagnostics either have high false results or risky, it’s important to 
have better diagnostics and earlier diagnosis of prostate cancer. Aberrant glycosylation is 
a hallmark of cancer. When cancer occurs, aberrant glycosylation occurs, therefore, 
glycosylation patterns may provide information about different cancer types and 
metastatic potential. In order to study and use these glycosylation patterns, the boronic 
acid functionalized synthetic lectins that can interact with glycans have been developed. 
The work described here focuses on 1) the structure activities of synthetic lectins (SLs), 
especially SL11 which is selected against the prostate cancer cell line PC3, for 
developing a structure-activity relationship for the SL11 with both purified glycoproteins 
and proteins from prostate cell lines, 2) study the ability of an array of SLs to classify 
prostate cancer cell lines and colon cancer cell lines.  
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CHAPTER 1 
INTRODUCTION AND BACKGROUND 
1.0 ABSTRACT 
            During the onset of cancer, the expression of glycans and glycosylation pattern 
will change.1 Cancer-associated glycans contribute to tumor invasion, metastasis, and 
angiogenesis.2 So, these patterns can be used to diagnose cancer. Therefore, a boronic 
acid functionalized synthetic lectin array has been developed. The array was selected 
against purified glycoproteins and they showed a great ability to classify cell lines of 
different types. In this chapter, the importance of synthetic lectins, glycans or 
glycoproteins in the diagnosis of cancer, the strategy of developing sugar sensor array as 
well as the ability of the array to discriminate different cell lines will be explained. 
1.1 THE IMPORTANCE OF SYNTHETIC LECTIN 
              Prostate cancer is the second most common cancer in men in the United States. 
It is the second leading cause of death from cancer in men.3 The American Cancer 
Society estimated new prostate cancer cases in the United States for 2015 were about 
220,800. About 1 in 7 men will be diagnosed with prostate cancer within his lifetime. 
Prostate cancer can grow slowly for years without painful symptoms but it can also grow 
quickly to become a metastatic disease to endanger a patient’s life. This makes earlier 
and better diagnosis very important. Current approaches to diagnose prostate cancer 
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include PSA blood test, digital rectal exam, transrectal ultrasound, prostate biopsy etc.4 
However, some of these diagnostics sometimes lead to false positive, false negative or 
painful symptoms to patients. For example, the PSA blood test can have a false positive 
up to 75% according to the American Cancer Society.4 So a better prostate cancer 
diagnostic is in great need.  
             
 
 
 
 
 
 
 
 
 
 
            In cells, there is a process adding glycans to proteins which is important in cell 
recognition, adhesion, and proliferation.5 This process is called glycosylation. Over 70% 
of proteins are glycosylated in cells. Cancer cells frequently display glycans at different 
levels or with fundamentally different structures than those observed on normal cells.6 
Unusual glycosylation patterns indicate specific diseases such as cancer and serve as 
biomarkers in clinical diagnosis.7 One of the well-known examples is the prostate specific 
antigen (PSA) from tumor cells, which contains a higher level of fucose and absence of 
 
Cancer 
glycan 
Malignant tissue 
Ovary Pancreas Blood Breast Colon Brain Prostate Skin Lung 
sLex  X  x x    x 
sLea  X  x x    x 
sTn x X  x x  x  x 
TF x   x x  x   
Ley x X  x x  x  x 
GloboH x X  x x  x  x 
PSA  X x x  x   x 
GD2   x   x  x  
GD3      x  x  
Fucosyl 
GM1 
        x 
GM2 x X x x x x x x x 
 
Table 1.1 Common expression of cancer associated glycans on malignant tissues. 
 3 
 
sialic acid compared with PSA from normal cells.8 Cancer associated glycans (CAGs) 
can be overexpressed differently among cell types which can provide an opportunity for 
cancer diagnosis. While there is no specific CAGs for detection of a single type of cancer 
at an early stage, aberrant glycosylation of different glycans could form a pattern that 
could be used for cancer diagnosis. For instance, in Table 1.1, sLex is over-expressed in 
pancreas, breast, colon, and lung cancer while not on other kinds of cancers. 9   But other 
glycans are expressed abnormally for other cancers. So using only one of these aberrant 
glycans can not tell what type of cancer it is while by looking at the pattern of different 
glycans, we can figure out the specific cancer type.  
            Lectins are defined as proteins that preferentially recognize and bind carbohydrate 
complexes from glycolipids and glycoproteins.10 These could be used to detect the pattern 
of glycans of different kinds of cancers at different stages. However, natural lectins are 
expensive to obtain and there are not many natural lectins commercially available. In 
order to mimic the function of natural lectins, synthetic lectins, boronic acid 
functionalized short peptides, were developed. Synthetic lectins are glycan sensors 
designed to have a covalent yet reversible interaction between boronic acids and the diols 
present on the saccharides.  
1.2 BORONIC ACID-DIOL INTERACTION 
            Boronic acid is well-known to form covalent yet reversible interactions with 1, 2 
or 1, 3-diols presented on sugars, as seen in Figure 1.1.11 The boron atom of boronic acid 
in its neutral form is a sp2 hybridization atom with 6 valence electrons forming 3 bonds in 
a trigonal plane orientation. A vacant p orbital is perpendicular to it, which makes it a 
good electron acceptor to fill its open shell and achieve a stable octet state. Therefore, 
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boronic acid has a high tendency to react with a Lewis base such as hydroxyl groups. 
This interaction empowers boronic acid receptors’ glycan binding capacities and makes 
them a class of lectin mimetic. The interaction of boronic acids with cis-1,2- or 1,3-diols 
to form five- or six-membered cyclic esters is covalent yet reversible. Boronic acids can 
also bind to glycans in multivalent binding that enhances both affinity and selectivity. 
The strength of boronic acid binding to saccharides can be adjusted by the relative 
position of boronic acid and the multivalent interaction thus boronic acids can 
differentiate structurally similar saccharide molecules, rendering boronic-acid based 
glycan sensing in biologically relevant scenarios possible.  
       
                Figure 1.1 Boronic acids and cis-diols interaction. 
 
1.3 MULTIVALENCY AND MONOVALENCY  
            Carbohydrate and protein interactions are very important since many biological 
events such as cell recognition, migration, and apoptosis are mediated by protein– 
carbohydrate interactions12. These biological communication processes rely on speciﬁc 
adhesion to cell surface carbohydrate epitopes.13 Although the protein-carbohydrate 
interactions have so many roles in biological processes, these interactions are very weak, 
induced by the weak affinity of saccharides for their protein receptors, lectins; binding 
events typically proceed with millimolar to micromolar dissociation constants.14   In 
nature, in order to increase the binding affinity between carbohydrates and lectins, 
 
Figure 1.2 Interaction between boronic acids and cis-diols. 
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multivalent interactions are widely used.15 Multivalency can be understood as the ability 
of  proteins to bind to multiple binding sites on carbohydrates, making low affinity events 
into physiologically relevant affinities to have more than additive affect.16  This is very  
important to increase the binding affinity and induce selectivity because when one bond 
between a glycan and lectin breaks, the other glycan is still binding to another position on 
the lectin so the interaction does not break. On the cell surface or in the cells, there are a 
lot of sugar moieties. When disease happens, the sugars will be over, under, or neo-
expressed. By synthesizing cancer sensors-synthetic lectins, which can induce 
multivalent interaction and have different binding affinities with different sugars, diseases 
can be diagnosed. Multivalent interactions and monovalent interactions are shown in 
Figure 1.2. 
1.4 COMBINATORIAL CHEMISTRY         
           In previous work, synthetic lectins (SLs) libraries and an SL array have been 
made. The SLs in the array were chosen from SL libraries. SL libraries were synthesized 
 
                  
                Figure 1.2 Multivalent and monovalent interaction. 
 
 
monovalency
multivalency
receptor ligand complex
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using the split-and-pool method. Peptides are good scaffolds to make biological sensors. 
Resins were divided equally to several vials for coupling the amino acid. After coupling 
amino acids and deprotecting, resins were mixed and divided equally to several vials 
again. The procedure can be repeated several times until all the desired amino acids are 
coupled (Figure 1.3). Each bead contains its unique compound and has thousands of 
copies of the same molecules on the same bead. The resulting bead-based library was 
then screened against different relevant targets. Fluorescein isothiocyanate (FITC)-
labeled glycoproteins, including ovalbumin (OVA), bovine submaxillary mucin (BSM), 
and porcine stomach mucin (PSM), were incubated with the libraries in the presence of 
1% BSA (bovine serum albumin) and 10% glycerol. Microscope was then used to detect 
any bright beads. Beads selective or cross reactive with OVA, BSM, or PSM were 
observed. These bright beads were manually picked out and sequenced. SL1-SL9 were  
selected this way.  
 
 
 
Figure 1.3 Split-and-pool combinatorial methods to generate peptide libraries. 
 
 
Split
Amino Acid, HBTU
DMF, 5% N-Mm,
Pool
20% piperidine 
in DMF
 7 
 
 
1.5 ARRAY BASED DISCRIMINATION 
        The enzymes catalyze chemical reactions by binding the substrate to the active site 
on the enzyme. The shape of the active site is complementary to the geometric shape of a 
substrate molecule, which is similar to the mechanism of a lock and key. Therefore it’s 
called a “lock and key” binding mode. In this analogy, the lock is the enzyme and the key 
is the substrate. Only the correctly sized key (substrate) fits into the key hole (active 
site) of the lock (enzyme). These specific interactions can be mimicked for sensor design. 
An array includes receptors to generate fingerprint patterns for each analyte, and does not 
require one particular receptor to differentiate between analytes, but depends on the 
general response from several receptors for each analyte.  This approach of sensing is 
inspired by the senses of taste and smell. The taste receptor cells in your taste buds make 
the taste sensations-bitter, sweet, sour, etc., so your brain can feel the pattern of the taste 
sensations to give a “flavor” of the food you eat. The sensing elements chosen in the 
array could be either selectively binding to the analytes with high binding affinity or have 
low affinity to the analytes. However, these receptors should have different binding 
affinities with the analytes in order for the array to differentiate between analytes. The 
response of a single sensor element may not be able to identify the analyte. Instead, the 
overall response of the receptors contributes to the formation of a specific pattern to 
recognize the analyte, which is also called “pattern-recognition” (Figure 1.4).17 This 
approach could be explored to distinguish a variety of different analytes.   
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1.6 PREVIOUS SYNTHETIC LECTIN ARRAY WORK 
It’s well-known that boronic acids can react with the diols on sugars and form 
covalent yet reversible interaction with 1, 2 or 1, 3-diols presented on sugars, as seen in 
Figure 1.2. Our lab incorporated boronic acids on a peptide backbone to make a synthetic 
lectin (SL) array. These SLs contain boronic acid moieties on the peptide backbones that 
can bind to the diols on the glycoproteins on cells with different binding affinities thus 
could be used to classify healthy and cancerous cells. The array contains SL1-SL9 that 
share similar sequences: Ac- RXD*(X)3D*XBBRM-resin (Figure 1.5). The resin our lab 
used is Tentagel amino resin. M, R, B and D* represent methionine, arginine, beta-
alanine and boronic acid functionalized Dab. The Xs are random amino acids depending 
on the synthetic lectins.         
           Our lab used peptide as a backbone and incorporate boronic acids into the side 
chain of a diamino-butyric acid (Dab), which is a non-natural amino acid. Both natural 
and non-natural amino acids were used in order to increase the diversity of the synthetic 
lectins. A synthetic lectin library was made using the “split and pool” method. After the 
 
 
   Figure 1.4 Scheme of cross-reactive receptors array. 
 
 
 Single Analyte Pattern
Read
Out
Differential Receptors
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library was synthesized, it was incubated with fluorescently labeled purified 
glycoproteins and screened against these labeled purified glycoproteins. The 
glycoproteins our lab used were ovalbumin (OVA), porcine submaxillary mucin (PSM) 
and bovine submaxillary mucin (BSM). Bovine Serum Albumin (BSA) was selected as a 
control protein since it does not have glycans associated with it. These glycoproteins vary 
in size, content of carbohydrates and the types of glycans incorporated, thus to select 
cross reactive SLs. Ovalbumin is a relatively small N-linked glycoprotein (M.W. 45 
KDa), contains 3% carbohydrates (mannose and N-acetylglucosamine) by weight of 
protein.18 The PSM and BSM belong to mucins family which are high-molecular weight 
glycoproteins.  
 
 
 
 
 
Figure 1.5 Schematic depiction of a bead-based boronic acid functionalized synthetic  
lectin. 
           
           Higher fluorescence intensity beads suggest stronger binding. The specific beads 
which had higher affinity for particular glycoproteins were termed “hits”. These “hits” 
were manually picked out, the SLs are cleaved from the beads, and then MS-MS spectra 
was performed to get the sequence of these “hits” by former labmates. The sequences for 
the synthetic lectin array that includes synthetic lectins 1 to 9 are listed in Table 1.2.       
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                              Table 1.2 Sequence information of SL1-SL9. 
 
SL Name Sequence 
SL1 Ac-RGD*VTFD*RBBRM 
SL2 Ac-RTD*RFLD*VBBRM 
SL3 Ac-RSD*VTTD*RBBRM 
SL4 Ac-RRD*TQTD*QBBRM 
SL5 Ac-RAD*TRVD*VBBRM 
SL6 Ac-RTD*NRND*FBBRM 
SL7 Ac-RSD*YFTD*QBBRM 
SL8 Ac-RTD*YGND*NBBRM 
SL9 Ac-RTD*YQVD*ABBRM 
 
1.7 DISCRIMINATION OF CELL LINES  
            In order to test the ability of SL array to classify cell lines, seven cell lines were 
used. These cell lines belong to 3 categories. As shown in Table 1.3, NIH/3T3 is a normal 
cell line, whereas HT29, HCT116 and CT-26 belong to cancerous/non-metastatic cell  
 
Cell line Cell lines Organism Cancerous
Mouse CT-26 colon Cancerous (˂10%)
Mouse CT-26-F1 colon Cancerous (50%)
Mouse CT-26-FL3 colon Cancerous (90%)
Human LOVO colon Cancerous (high metastatic)
Human HT-29 colon Cancerous (low metastatic)
Human HCT116 colon Cancerous (low metastatic)
Mouse NIH/3T3 embryo Normal
Table 1.3 Seven cell lines used in the classification. 
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lines, and CT-26-F1, CT-26-FL3 and LoVo are cancerous/metastatic. SL1, 3, 4 and 5 
were used to distinguish the 7 cell lines. Membrane proteins and glycoproteins were 
prepared and fluorescently labeled with FITC and dialyzed to remove excess FITC. 
Fluorescently labeled extracts were collected and their absorbance and fluorescence were 
measured. SL1,3,4 and 5 were individually incubated with a 50 fold dilution of each 
FITC labeled membrane extract for 6h, and washed with screening buffer. Then the beads 
were imaged using the fluorescence microscope and fluorescence intensity was analyzed. 
Linear discriminant analysis (LDA) was used to analyze the data. LDA is a statistical 
method, which minimizes the variation within a cell type while maximizing the 
difference between cell types. Leave-one-out cross-validation was used to estimate the 
classification accuracy. Each time one sample point was taken out, the rest of the points 
formed a new training set. The classification accuracy was determined by whether or not 
the excluded point was classified to the correct cell type group. Seven cell lines were 
divided into three categories based on metastatic potential. As shown in Table 1.3, 
NIH/3T3 is a normal cell line, whereas HT29, HCT116 and CT-26 belong to 
cancerous/non-metastatic cell lines, and CT-26-F1, CT-26-FL3 and LoVo are 
cancerous/metastatic. The classification accuracy was 97% (LDA plot shown in Figure 
1.6). The results demonstrated that the SL array is capable of distinguishing healthy, 
cancerous and metastatic cells. 
 12 
 
  
 
1.8 CONCLUSION 
            Aberrant glycosylation occurs as the cancer begins.19 These glycans display a 
unique pattern for each cell type, providing the opportunity to detect cancer. Synthetic 
lectins (SLs), which are cheap, non-toxic, and easy to synthesize, have drawn much 
attention. The peptide backbone of the SLs use various natural and non-natural amino 
acids and the boronic acid can form covalent bonds with glycans. So the diversity of SLs 
and the interaction between SLs and glycans are guaranteed. The combination of the 
-6 -4 -2 0 2 4 6
-4
-2
0
2
4
-6 -4 -2 0 2 4 6 8
-4
-2
0
2
4
-6 -4 -2 0 2 4 6
-4
-2
0
2
HT29   (    )
HCT116   (   )
CT-26   (    )
CT-26-FL3   (   )
LoVo (    )
CT-26-F1   (    )
NIH/3T3 (    )
Cancerous/non-metastatic   (   )
Cancerous/metastatic   (    )
A.
B. C.
 
Figure 1.6 The 2-dimensional LDA plot of the patterns of the SL array to 
discriminate cells grouped by metastatic potential.  
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synthetic lectins and the boronic acids provides a great potential for the array to be used 
as a sensor (either as a selective sensor or in array format) for identification of 
glycosylated molecules. Our lab has been focused on the use of boronic acid based 
synthetic lectins as sensors for the past several years. The boronic acid functionalized 
sensor array for cancer associated glycans is developed. The SL sensor array is able to 
classify healthy, cancerous and highly metastatic cells.  
1.9 REFERENCES 
1.Bertozzi, C. R.; Dube, D. H., Glycans in cancer and inflammation. Potential for 
therapeutics and diagnostics. Nat. Rev. Drug Discov. 2005, 4, 477-488. 
2. Ghazarian, H.; Idoni, B.; Oppenheimer, S. B., A glycobiology review: carbohydrates, 
lectins, and implications in cancer therapeutics. Acta Histochem 2011, 113, 236–247. 
3. Siegel, R. L.; Miller, K. D.; Jemal, A., Cancer Statistics. CA Cancer J. Clin. 2015, 6, 
5–29. 
4. Cancer Facts & Figures. American Cancer Society 2015. Available online: 
http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2015/ 
5. Ghazarian, H.; Idoni, B.; Oppenheimer, S. B., A glycobiology review: carbohydrates, 
lectins, and implications in cancer therapeutics. Acta Histochem. 2011, 113, 236–247. 
6. Nie, H.; Liu, X.; Zhang, Y.; Li, T.; Zhan, C.; Li, Y., Specific N-glycans of 
Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-
fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa 
Regulation. Scientific Reports. 2015, 5, 16007.    
7.  Nolen, B. M.; Lokshin, A. E., Protein biomarkers of ovarian cancer: the forest and the 
trees. Future Oncol. 2012, 8, 55–71. 
8. Peracaula, R.; Tabares, G.; Royle, L.; Harvey, D. J.; Dwek, R. A.; Rudd, P. M.; de 
Llorens, R., Altered glycosylation pattern allows the distinction between prostate-specific 
antigen (Psa) from normal and tumor origins. Glycobiology.  2003, 13, 457-470. 
9. Bertozzi, C. R.; Dube, D. H.,Glycans in cancer and inflammation. Potential for 
therapeutics and diagnostics. Nat. Rev. Drug Discov. 2005, 4, 477-488. 
10. Ghazarian, H.; Idoni, B.; Oppenheimer, S. B., A glycobiology review: carbohydrates, 
lectins, and implications in cancer therapeutics. Acta Histochem. 2011, 113, 236–247. 
11. Bicker, K. L.; Sun, J.; Lavigne, J. J.; Thompson, P. R., Boronic Acid Functionalized 
Peptidyl Synthetic Lectins: Combinatorial Library Design, Peptide Sequencing, and 
Selective Glycoprotein Recognition. Acs Comb. Sci. 2011, 13, 232-243. 
12. Lis, H.; Sharon, N., Lectins:  Carbohydrate-Specific Proteins That Mediate Cellular 
Recognition. Chem. Rev. 1998, 98, 637–674. 
13. Mangold. S. L.; Cloninger. M. J., Binding of monomeric and dimeric Concanavalin A 
to mannose-functionalized dendrimers. Org. Biomol. Chem. 2006, 4, 2458-2465. 
14. Toone.E.J., Structure and energetics of protein-carbohydrate complexes. Curr. Opin. 
Struct. Biol. 1994, 4, 719–728. 
 14 
 
15. Mammen.M.; Choi. S. K.; Whitesides. G. M., Polyvalent Interactions in Biological 
Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. Angew. 
Chem. Int. Edit. 1998, 37, 2754– 2794. 
16. Lee, R. T.; Lee, Y. C., Affinity enhancement by multivalent lectin-carbohydrate 
interaction. Glycoconj. J. 2000, 17, 543-551. 
17. Anslyn, E. V.; Folmer-Andersen, J. F.; Kitamura, M., Pattern-based discrimination of 
enantiomeric and structurally similar amino acids: An optical mimic of the mammalian 
taste response. J. Am. Can. Soc. 2006, 128, 5652-5653. 
18. Suzuki, T.; Kitajima, K.; Emori, Y.; Inoue, Y.; Inoue, S., Site-specific de-N-
glycosylation of diglycosylated ovalbumin in hen oviduct by endogenous peptide: N-
glycanase as a quality control system for newly synthesized proteins. Proc. Natl. Acad. 
Sci. U. S. A. 1997, 94, 6244-6249. 
19. Bertozzi, C. R.; Dube, D. H., Glycans in cancer and inflammation. Potential for 
therapeutics and diagnostics. Nat. Rev. Drug Discov. 2005, 4, 477-488. 
 
 
 15 
 
   CHAPTER 2 
STRUCTURE ACTIVITY RELATIONSHIP STUDY 
2.0 ABSTRACT 
 In this chapter, the main focus is on the structure-activity relationship of synthetic 
lectin 11 (SL11) with proteins. Prostate cancer is now the second leading cause of cancer 
death in American men. The American Cancer Society estimated new prostate cancer 
cases in the United States for 2015 were about 220,800. About 1 in 38 men will die of it.1 
There have been diagnostics for prostate cancer. Main methods include PSA (prostate 
specific antigen) blood test, digital rectal exam, biopsy, etc. However, these diagnostics 
are not perfect. For instance, PSA test may have a 75% false positive according to 
American Cancer Society. Biopsy can be a more accurate method to diagnose prostate 
cancer, but the process is painful and it’s possible to cause infection to the patient. 
Therefore, it’s important to have better diagnostics and earlier diagnosis of prostate 
cancer. Glycosylation is a reaction in which a carbohydrate is attached to a hydroxyl 
group or other groups of another molecule. It occurs in biological system. Aberrant 
glycosylation occurs during the onset of cancer.2 The glycosylation patterns can indicate 
the disease states. As discussed previously in Chapter one, in order to study and use these 
glycosylation patterns, a synthetic lectin array has been developed. The array contains 
SL1 to SL9. These SLs were selected against purified glycoproteins and they showed a 
great ability to classify purified glycoproteins and cell lines of different types.3 Now our
 16 
 
lab has began to choose synthetic lectins against cell lines. The library generating process 
is the same as that of previous described. But this library was screened against both 
cancerous and noncancerous cell lines.  
            The work described here used synthetic lectin 11 (SL11) which was selected 
against prostate cancer cell line PC3 as well as a series of mutants of SL11 for developing 
a structure-activity relationship of SL11 with both purified glycoproteins and proteins 
from prostate cell lines.  
2.1 INTRODUCTION 
            Previous study has shown that the SLs in a SL array were able to effectively 
distinguish five structurally similar glycans with 94% accuracy, and seven normal, 
cancerous and metastatic colon cancer cell lines, including three isogenic cell lines, with 
92% accuracy.3 Although the SL array can discriminate cell lines very well, we still don’t 
fully understand what components in the SLs are playing important roles in the binding 
with glycoproteins or in discrimination. From the sensor design perspective, 
understanding the binding mechanism will provide useful information for the future 
sensor design. If we can figure out which structure in the SL can increase binding affinity 
and selectivity or which structure is important in the discrimination, we can gradually 
improve the SL array towards a better prostate cancer diagnostic.  
In the previous study, different components on the SLs were changed to see how these 
structures affect binding affinity. Our group4 synthesized SL2 (D*3, 7 A), a mutant of 
SL2 (a hit that shows moderate selectivity for ovalbumin) that change boronic acid 
functionalized diamino butyric acid (Dab) to alanine in order to explore the SL-
glycoprotein binding. Compared to SL2, SL2 (D*3, 7 A), which no longer had boronic 
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acid on it, had very little association with all the glycoproteins. SL2-BAD was also 
synthesized in previous study. SL2-BAD replaced 2-formylphenylboronic acid with 
benzaldehyde. Compared with SL2, the absence of boronic acid caused a loss of 
selectivity. These initial studies indicated that boronic acid-diol interaction could affect 
for SL binding and selectivity. They also mutated charged amino acid like arginine. 
According to their study, charged amino acids are also useful for binding. This agreed 
well with another previous study. 
            According to another point mutation study on SL5, positively charged arginine is 
important for the binding of SL 5 with colon cancer cell lines, and by adding more 
arginine on SL5, the binding affinity between SL5 and colon cancer cell lines increases. 
That maybe because that colon cancer cells have abundant negatively charged sugars that 
have sialic acid components, which agrees with the facts.5  
            SL11 was selected against cell lines in previous study by Anna Veldkamp. 
RWPE_1 cell line and PC3 cell line were used. RWPE_1 cell line is a healthy prostate 
cell line and PC3 cell line is a highly metastatic prostate cell line, which is generated 
from bone metastasis cells. A portion of a SL library was incubated with a mixture of 
FITC labeled RWPE_1 cell membrane (green under green protein filter) proteins and 
Rhodamine labeled PC3 membrane proteins (red under red protein filter).  A “hit” was 
found, which was bright under red protein filter of microscope while looking like other 
beads under green protein filter. That indicated the SL on that bead bound to some 
proteins or glycoproteins of PC3 while these proteins were not abundant on RWPE_1.  
The “hit” was manually picked out by Anna Veldkamp and Edman degradation was 
performed to recover the sequence of SL on the bead. The SL was name SL11.  SL11 has 
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been used in the discriminant of cell lines and showed a great potential to increase the 
classification accuracy of cell lines. Therefore, it’s been an interest of our research. Point 
mutation studies of SL11 were explored to determine which amino acid is important for 
the binding. 
2.2 SYNTHESIS OF SL11 MUTANTS 
            As mentioned above, point mutation on SL11 was explored to determine which 
amino acids are important in the binding between SL11 and the glycoproteins. SL11 was 
selected out of the dual dye competitive binding between RWPE_1 and PC3 cell line. It 
showed selectivity for PC3 over RWPE_1. A series of mutants were made based on it. 
Shown in Table 2.1. D* is the boronic acid functionalized Dab. There are 2-
phenylboronic acids (2-PBA) on Dabs and the arginine on the first position. The beads 
used were Tentagel beads, which had amine groups on the beads.  Methionine (M) was 
coupled first, followed by arginine (R), beta-alanine (B), and beta-alanine. Then a peptide 
synthesizer was used to couple the rest of the amino acids to the beads. Then boronic 
acids were coupled on the Dabs and the arginine on the N –terminus. The synthesis of the 
SL11 and its mutants was confirmed by MALDI analysis. The corresponding molecular 
weight of SL11 is 1751 Da, which is consistent with the calculated value. To see the 
structure activity of SL, specially to see the structure activity of charged or “polar” amino 
acids, SL11(R8A), SL11(T6A), and SL11(Y4A) were synthesized. Arginine was 
replaced by alanine because it has a positively charged group on the side chain and it may 
form a salt bridge with negatively charged glycoproteins, such as OVA, BSM, and PSM. 
Threonine and tyrosine were replaced by Alanine, too. This is because that there are –OH 
groups on the side chain of threonine and tyrosine, and they may form hydrogen bonds 
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with glycoproteins.  
                 Table 2.1 SL11 and SL11 mutants. 
 
 
 
 
 
 
2.3 EFFECT OF AMINO ACID RESIDUES OF SL11 BINDING PURIFIED 
GLYCOPROTEINS 
            The effect of amino acid residues was first explored by incubating the SLs with 
purified glycoproteins and proteins. SL11 and the mutants were individually incubated 
with 0.1 mg/ml FITC labeled BSA, OVA, BSM, and PSM overnight at room 
temperature, and washed with phosphate-buffered saline (PBS). All images were taken 
with a Leica MZ 16F microscope and a GFP filter set. The glycoproteins vary in size, 
content of carbohydrates and the types of glycans incorporated (Table 2.2). Ovalbuminis 
a relatively small N-linked glycoprotein (M.W. 45 KDa).6 It contains 3% carbohydrates 
(mannose and N-acetylglycosamine) by weight of protein.7  The mucins families are more 
glycosylated and with high molecular weights. They contain more than 50% of 
oligosaccharides by weight. The glycans on the mucins are principally attached to serines 
and threonines via O-linkages. BSM contains N-acetylgalactosamine, N-
acetylglucosamine, galactose, and fucose with 56.7% carbohydrates by weight of protein. 
Its molecular weight is 400 KDa.8 PSM contains similar carbohydrates with BSM and has 
1 SL11 2-PBA-RLD*YLTD*R-BBRM-resin 
2 SL11(R8A) 2-PBA-RLD*YLTD*A-BBRM-resin 
3 SL11(T6A) 2-PBA-RLD*YLAD*R-BBRM-resin 
4 SL11(Y4A) 2-PBA-RLD*ALTD*R-BBRM-resin 
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a molecular weight of 1000 KDa,8 and the content of carbohydrates ranges from 60% to 
90% by weight of protein.9 These purified glycoproteins contain complex N-linked and 
O-linked glycans, some of which (e.g. sialic acid) are known to be associated with 
cancers. Therefore, these glycoproteins were chosen as model glycoproteins for proof-of-
concept studies. An additional benefit is that these glycoproteins are inexpensive and 
commercially available. MATLAB is used to extract information about fluorescence and 
quality of the resin. According to the luminosity, we can know the binding affinity 
between SL and the glycoproteins. The results are shown in figure 2.1. The results were 
based on 3 measurements and each measurement had around 60-100 replicates. The data 
was normalized against each protein with SL11. We can see from SL11 and SL11 (R8A), 
charge may play a role in the binding between SLs and glycoproteins. We can see that 
once we replaced an arginine by alanine, the binding affinity between the SLs and the 
glycoproteins decreased, which indicates charge may help with the binding. According to 
the results from SL11 and SL11 (T6A), Hydroxyl groups may also be involved in the 
binding. Once we replace threonine by alanine, we see the binding decrease, although not 
as big as when we replace the arginine. This may be due to the fact that –OH can form 
hydrogen bonds with proteins. But when we change threonine to alanine, we also get rid 
of a methyl group, so this potentially reduces the steric hindrance induced by the methyl 
Proteins
Molecular 
Weight
Major Associated Carbohydrates
Content of 
Carbohydrates
Ovalbumin 45 KDa Mannose, N-acetylglucosamine 3.2%
Bovine Submaxillary 
Mucin (BSM)
400 KDa
Sialic acid, N-acetylgalactosamine, 
Galactose, Fructose
＞50%
Porcine Stomach 
Mucin (PSM)
1000 KDa
Similar to bovine submaxillary 
mucin
60-90%
Carcinoembryonic 
Antigen (CEA)
200 KDa
Fucose, Sialic acid, Galactose, 
Mannose, N-acetylglucosamine
50-80%
Table 2.2 Information of purified glycoproteins. 
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group. So further experiments need to be done to investigate which structure plays a 
bigger role. Amino butyric acid (Abu) has a structure similar to threonine, only without 
the –OH. So in further study, SL11 (T6Abu) needs to be made to better control the 
variables. Phenyl group may negatively affect the binding according to the comparison of 
the results between SL11 and SL11 (Y4A). In a PSM binding study, there was an 
increase when we replaced the tyrosine by alanine.  But the binding affinity with OVA 
decreased after the removal of phenol group. This could mean the OVA has a positive 
interaction with the phenyol group on tyrosine. In later study, more mutants like SL11 
(Y4F), which replace phenol group to a phenyl group, were made in order to better 
control the variables. By combining the data from SL11, SL11 (Y4A), and SL11 (Y4F), 
it’s possible for us to have a better understanding of the importance of the phenyl group. 
Therefore, charge, hydroxyl group, and phenyl group may play roles in the binding. More  
 
mutants were later made to figure out how these affect binding affinity between SLs and 
glycoproteins.  
 
Figure 2.1 Structure activity relationship of SL11 with purified glycoproteins. 
0.6
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 22 
 
2.4 EFFECT OF AMINO ACID RESIDUES OF SL11 BINDING PURIFIED 
GLYCOPROTEINS USING MORE MUTANTS 
            Additional mutants were made to study the activity relationship of SL11 with 
purified glycoproteins.   Four more SL11 mutants were made. All the mutants of SL11 
and SL11 are shown in table 2.3. L, Y, T, A, F, represent leucine, tyrosine, threonine, 
alanine and phenylalanine respectively. Abu is a kind of non-natural amino acid, which 
represents amino-butyric acid. SL11 (L5A) and SL11 (L2A) were made to investigate the 
steric hindrance induced by leucine, which is a relatively big amino acid. SL11 (Y4F) 
was made and by comparing SL11, SL11 (Y4A) and SL11(Y4F), we are able to gain an 
insight into the structure activity of tyrosine. By comparing SL11, SL11 (T6A) and SL11 
(T6Abu), we are able to gain an insight into the structure activities of threonine.  
                   Table 2.3 SL11 and SL11 mutants. 
 
    
 
 
 
 
 
            The SLs were synthesized and confirmed by MALDI-MS analysis. The 
corresponding molecular weights of the SLs were consistent with the calculated values. 
SL11 and the mutants were individually incubated with 0.1 mg/ml FITC labeled BSA, 
OVA, BSM, and PSM overnight, and washed with PBS. All images were taken with a 
Leica MZ 16F microscope and a GFP filter set. SL2, SL5 and SL6, which were selected 
1 SL11 2-PBA-RLD*YLTD*R-BBRM-resin 
2 SL11(R8A) 2-PBA-RLD*YLTD*A-BBRM-resin 
3 SL11(T6A) 2-PBA-RLD*YLAD*R-BBRM-resin 
4 SL11(Y4A) 2-PBA-RLD*ALTD*R-BBRM-resin 
5 SL11(L5A) 2-PBA-RLD*YATD*R-BBRM-resin 
6 SL11(L2A) 2-PBA-RAD*YLTD*R-BBRM-resin 
7 SL11(Y4F) 2-PBA-RLD*FLTD*R-BBRM-resin 
8 SL11(T6Abu) 2-PBA-RLD*YLAbuD*R-BBRM-resin 
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against purified glycoproteins, were also used as controls to see if they bind to purified 
glycoproteins better than SL11, which is selected against cell lines, and its mutant. 
Different from SL11 and its mutants, these SLs have 2 boronic acids instead of 3. The 
results are shown in Figure 2.2. The data were normalized against the average of the bead 
intensity within each protein. 
 
 
             
            Generally speaking, SL2, SL5, and SL6  bind to BSM and PSM better than SL11 
and the mutants. That’s maybe because there are some galactose and fucose in BSM and 
PSM but are not in OVA and BSA. SL2, SL5, and SL6 may bind to thses glycans better 
than SL11 and its mutants, even with less boronic acids. The pattern of binding to all SLs 
for BSM is almost the same as the pattern of PSM, which agreed very well with the fact 
that BSM and PSM has similar contents. SL11 (R8A) always has reduced binding to 
purified glycoproteins and proteins versus SL11. That indicates charge plays a role in the 
binding of SLs with glycoproteins an proteins. There is not a significant difference 
between SL11 (T6A) and SL11 (T6Abu) with proteins. Also, there is not a significant 
0
0.2
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0.6
0.8
1
1.2
1.4
BSA BSM OVA PSM
SL11 SL11(R8A) SL11(T6A) SL11(Y4A) SL11(L5A) SL11(L2A)
SL11(Y4F) SL11(T6Abu) SL2 SL5 SL6
Figure 2.2. Structure activity relationship of SL11 and mutants with purified 
glycoproteins 
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difference between SL11(Y4A) and SL11 (Y4F). These Suggested that phenyl group did 
not affect the binding between SLs and purified glycoproteins a lot. 
2.5 EFFECT OF AMINO ACID RESIDUES OF SL11 ON CELL MEMBRANE 
PROTEINS 
           RWPE_1 and PC3 were used to study the structure-activity relationships of SLs 
with cell membrane extracts. RWPE_1 is a kind of epithelial cell from a 54-year-old 
white male donor that was immortalized with a single copy of HPV virus. PC3 is a 
metastatic cell line. The same Seven SL11 mutants were used. All the SLs are shown in 
table 2.3. Cells were cultured and the membrane proteins were isolated with a membrane 
protein kit. The SLs were washed with PBS for 3 times, and pre-blocked with 1% BSA in 
PBS with glycerol and then incubated with 0.0002 mg/ml labeled membrane proteins 
individually for 6 hours. The beads were then washed with PBS three times and imaged 
under a microscope using a GFP filter set. Matlab was used to extract the brightness of 
the beads. The brightness indicates the binding affinity of SLs with the proteins. 
            The results are shown in Figure 2.3. The data were averaged correspondingly and 
normalized against SL11. Therefore the SL11 is 0. Generally speaking, the mutants bond 
to PC3 better than SL11 and bond to RWPE_1 less than SL11. After the point mutation 
of arginine to alanine, the binding affinity with both cell lines did not change much. That 
may indicate in prostate cells the sialic acid residue, which has a negative charge is not 
abundant. So we didn’t see a decrease in the binding affinity after the mutation of 
arginine. When we changed threonine to amino butyric acid, the binding increased more 
in PC3 cell line than in RWPE_1, which indicate different cell lines have different 
preference with –OH group. This can be well used in the future research to better our 
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synthetic array. If we look at SL11 (L5A) and SL11 (L2A), we can find the leucine may 
help increase the binding affinity with PC3 while decrease the binding affinity with 
RWPE_1. This difference leucine made in different cell lines can be used to better 
classify cell lines. And at the same time, both PC3 cell line and RWPE_1 showed the 
potential to interact with the aromatic ring, because when the SL11 (T6Abu) and SL11 
(Y4F) were replaced by SL11 (T6A) and SL11 (Y4A), the binding decreased. 
  
 
2.6 CONCLUSIONS 
            To investigate the structure activity of SL11, a series of mutants were made. SL11 
was the focus of this study because it was selected against cell proteins instead of purified 
glycoproteins like OVA, BSM and PSM. Charged amino acids appear to be more 
important for binding with purified glycoproteins compared with cell membrane proteins. 
That’s possibly because that purified glycoproteins contain more negatively charged 
moieties than membranes proteins. Also, SL2, SL5, and SL6 bind to PSM and BSM 
better than SL11 and its mutants. That’s maybe because there are some galactose and 
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Figure 2.3 Structure activity relationship of SL11 and mutants with cell 
membrane extract. 
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fucose in BSM and PSM but are not in OVA and BSA. SL2, SL5, and SL6 may bind to 
these glycans better than SL11 and its mutants. The patterns of BSM and PSM with SLs 
are highly similar which agrees well with the fact that BSM and PSM have the same 
sugar contents. Generally speaking, the mutants bond to RWPE_1 better than SL11 with 
RWPE_1. This study only used one healthy and one metastatic prostate cell lines. Further 
studies will be continued using more cell lines and secreted proteins to investigate 
structure-activity relationship of SL11with glycoproteins.  
2.7 EXPERIMENTAL METHODS 
Chemicals  
All amino acids and O-Benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-
phosphate (HBTU) were purchased from Novabiochem Corp. Glycoproteins and FITC 
were purchased from Sigma-Aldrich. TentaGel resin (Cat. No. MB-300-002; loading 
level 0.25 mmol/g) was purchased from Rapp Polymere. All other chemicals were 
purchased and used without further purification.  
Microscope Usage  
A Leica MZ 16F microscope and a GFP filter set (excitation 450-490 nm; emission filter 
500-550 nm) were used to take images, which were analyzed by Malab to obtain 
luminosity values afterwards. The luminosity values, which indicate the fluorescent 
intensity of the beads tell us the binding intensity. High average luminosity values means 
brighter beads, which correspond to strong binders.  
General method for synthetic lectin synthesis 
Standard Fmoc/HBTU chemistry was used to extend the peptide backbone. The amino 
acids had Fmoc protected amines, while reactive side chains of the amino acids protected 
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by acid-labile protecting groups. The beads were first soaked in DMF for 10 mins, and an 
amino acid, which was pre-activated by HBTU, was added. After tumbling 1 h, the beads 
were washed with DMF, methanol and DMF. To remove the Fmoc group, 10 mL 20% 
piperidine in DMF was used. The next amino acid was coupled using the same procedure.  
All of the SLs used started with the same first four amino acids, BBRM, before 
introducing other amino acids. For SL1-SL9, acylated arginine was used to cap the ends. 
For SL11 and its series mutants, no acylation was used. Then, 2-Formalphenylboronic 
acid was incorporated onto diamino-butyric acid which is a non-natural amino acid.  
Incorporation of Phenyl Boronic Acid 
Th ivDde protecting groups on Dabs were removed with 10 mL of 5% (v/v) hydrazine 
monohydrate in DMF for 3 times. Then, 8 equivalent of 2-Formylphenyl boronic acid 
was dissolved in a mixture of 0.2 mL methanol and 9.8 mL DMF and the liquid was 
added to the beads along with activated 3Ǻ molecular sieves and tumbled at 37 ºC 
overnight.  NaBH4 was added and the cap was open for around 0.5 h to let the gas release 
and the resin was tumbled at 37 ºC for 4 h, followed by washing with DMF, methanol, 
and DMF. Molecular sieves were removed by adding DCM so the beads would flow 
while the molecular sieves were still at the bottom. So the beads can be transferred to 
another reaction vessel.  After the boronic acid moiety was coupled, 10 mL of 95% TFA, 
2.5% water, and 2.5% triisopropysilane was added to each SL and the resin was tumbled 
for 1 h to deprotect the acid-labile protecting groups. This process was repeated twice. 
The resin was then washed with DMF, methanol, and DMF. 
Phosphate Buffered Saline (PBS)  
Sodium phosphate monobasic (monohydrate) (27.6 g, 200 mmol), sodium phosphate 
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dibasic (anhydrous) (28.4 g, 200 mmol) and sodium chloride (35.06 g, 600 mmol) were 
dissolved in 4 L of DI water and the pH was adjusted to 7.2-7.3 using 3 M NaOH.  
Fluorescent Labeling of Purified Proteins  
To prepare the FITC labeled glycoproteins, 50 mg of the purified proteins (e.g. OVA, 
BSM, or PSM) was dissolved in 8 mL of 0.5 M carbonate buffer (pH= 9.8) and 4 mg of 
FITC was dissolved in 2 mL of DMF.  The two solutions were combined together in a 15 
mL Falcon tube and tumbled at 37 ºC for an hour.  The solution was then transferred to a 
10 kDa cut-off dialysis membrane and dialyzed in 0.1 M PBS (pH = 7.2). The dialysis 
buffer was changed every 4 hours until dialysis was complete. The concentration of the 
FITC-glycoprotein was determined using the Bradford assay.  
BCA Assay 
A Thermo Scientific BCA kit was purchased from VWR.  The protein was suspended in 
a small amount of phosphate buffered saline (PBS) and a serial of 2 mg / ml standard 
BSA protein was used. The standards as well as the sample were added to a 96 well plate 
in triplicate using 10 ul protein per well followed by 200 ul of the reagent from the BCA 
kit. The wells were mixed thoroughly placed in an oven for 30 minutes at 37°C.  After 
thirty minutes that plate was read on a plate reader at 562 nm.    
Cell Culture 
All supplements and media for RWPE_1 and PC3 cell lines were ordered from VWR.  
The complete growth medium used to expand RWPE-1 cells was K-SFM supplemented 
with recombinant human Epidermal Growth Factor (rhEGF) and Bovine Pituitary Extract 
(BPE).  The complete growth medium used to expand PC-3 cells was principally RPMI 
1640 and FBS.  The cells were grown in T75 flasks at 37°C. Complete growth medium 
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was pre-warmed before using by placing into a warm incubator before using. Complete 
growth medium was stored at 4°C when not using. 
Cell Extracts 
Cells were grown to 70%- 80% confluence and scraped. The cells were centrifuged and 
collected in a 15 ml Falcon tube.  Plasma membrane glycoproteins and proteins were 
extracted using the Qiagen Plasma Membrane Protein Kit. FITC in DMF was incubated 
with membrane proteins at 37°C for 1 hr.  In order to purify the proteins, the solution was 
then placed in an Amicon ® 10K centrifuge tube and dialyzed with PBS. 
Binding Studies with glycoproteins 
Weighed 2 mg of each SL into a centrifuge tube.  The SLs were then rinsed with PBS for 
10 minutes twice. The PBS was removed and 1% BSA in PBS with 10% glycerol was put 
in the tubes and incubated for 15 minutes in order to remove non-specific binding. Then, 
0.1mg/ml purified glycoprotein was added to SLs and incubated up to 21 hours at room 
temperature under aluminum foil. After incubating the beads were washed three times 
with PBS and imaged with a fluorescence microscope, Leica MZ 16F, using a GFP filter 
set. 
Binding Studies with cell extracts 
Weighed 2 mg of each SL into a centrifuge tube. The SLs were then rinsed with PBS for 
10 minutes for twice. The PBS was removed and 1% BSA in PBS with 10% glycerol was 
put in the tubes and incubated for 15 minutes in order to remove non-specific binding. 
The solution was then removed. Then, 0.0002 mg/ml membrane extracts was added to the 
SLs and then tumbled for 6 hours at room temperature under aluminum foil.  After 
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tumbling the beads were washed three times with PBS and imaged with a fluorescence 
microscope, Leica MZ 16F, using a GFP filter set. 
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CHAPTER 3 
 
CLASSIFICATION STUDY AND STRUCTURE ACTIVITY STUDY 
WITH SECRETED PROTEINS 
3.0 ABSTRACT 
           A very important use of synthetic lectins is cancer diagnosis. Therefore they have 
been used in the discrimination of cancers of different types. This chapter mainly focuses 
on application of our synthetic lectins to classify different cancer types and metastatic 
potential. Flow cytometry method was used as a new method to look at the bead 
fluorescent intensity, and small polystyrene beads were also used in this study. Besides 
using the synthetic lectin (SL) array to classify cancers, we are also interested in the 
structure-activity relationships of SLs with secreted proteins. So a structure-activity 
relationship was also investigated using secreted protein, which is a meaningful move 
that can help us gain an insight into the structure-activity relationship of SLs with 
secreted proteins, which can better mimic the proteins in blood in human body. 
3.1 INTRODUCTION  
            Glycans and glycoproteins on the cell surface will be over, under or neo-
expressed when the cancer occurs.1 Different cancer types may have different 
glycosylation patterns. Therefore different glycosylation patterns can be used for cancer 
diagnosis.2-4  Some of them have already been clinically applied. For instance, one widely   
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used diagnostic test measures the amount of prostate specific antigen (PSA) in patients’ 
serum, to monitor the stage of prostate cancer. Unfortunately, the PSA test does not work 
so well, with a false positive of 75%.5 
            The cell surface is complicated and there are a lot of different moieties. Therefore, 
it’s difficult to use only one sensor to detect a cancer.  So using a SL array is much more 
reliable to discriminate different cancer types. Each SL binds to a kind of cell’s proteins 
or glycoproteins differently from other SLs, and by combining the data from these SLs, 
we can create a pattern of the array which indicates the “flavor” of this type of cancer. 
Therefore, no highly specific binding is required to detect a cancer.  
A previous SL11 structure activity study with purified glycoproteins and 
membrane proteins showed that by changing the peptide sequences, the mutants display 
differences in the binding with proteins compared with SL11. Membranes proteins are 
“mimics” of tissue samples. Secreted proteins are proteins secreted by cells. Cells release 
proteins into the blood stream. Secreted proteins in serum are easier to acquire compared 
with those in tissue samples because biopsy do not need to be performed. The process of 
taking tissues from patients is painful. Therefore, secreted proteins in serum are good 
choices to use for the prostate cancer diagnosis. For cell lines, the secreted proteins in 
media are good mimics for serum proteins. So secreted proteins in media were used in 
this study.  
3.2 SYNTHESIS OF SL11 MUTANTS 
            Point mutation on SL11 was explored to determine which amino acid is important 
in the binding between SL11 and the secreted glycoproteins. SL11 and the same series of 
mutants were made as previously discussed in Chapter 2. They are shown in Table 3.1. 
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D* is the boronic acid functionalized Dab, a non-natural amino acid. These two Dabs are 
on the third and seventh position of the peptide backbone. The Arginine on the N 
terminal end was not acylated, therefore, there is one boronic acid on the N terminal end. 
Therefore, there are three boronic acids in total on each SL. There are one 2-
phenylboronic acid (2-PBA) on each Dab and the arginine on the first position. The 
synthesis of the peptides was confirmed by MALDI analysis. The sequences of all the 
mutants of SL11 and SL11 itself are shown in table 3.1.  
   Table 3.1 SL11 and SL11 mutants. 
 
 
3.3 STRUCTURE ACTIVITY RELATIONSHIP OF SL11 WITH PROSTATE CELL 
LINES. 
             In this study, secreted proteins and glycoproteins, which were isolated from the 
media, were used. RWPE_1, WPE_1NA22, WPE_1NB14, DU145, and PC3 were used to 
study the structure activities of SLs with cell proteins. RWPE_1 is a kind of epithelial cell 
from a white male donor that was immortalized with HPV virus, and they are not 
invasive.6 It’s a healthy cell line. Neoplastic cell lines WPE1-NA22 and WPE1-NB14 
were also used and they were derived from RWPE-1.7 They are lowly metastatic cell 
1 SL11 2-PBA-RLD*YLTD*R-BBRM-resin 
2 SL11(R8A) 2-PBA-RLD*YLTD*A-BBRM-resin 
3 SL11(T6A) 2-PBA-RLD*YLAD*R-BBRM-resin 
4 SL11(Y4A) 2-PBA-RLD*ALTD*R-BBRM-resin 
5 SL11(L5A) 2-PBA-RLD*YATD*R-BBRM-resin 
6 SL11(L2A) 2-PBA-RAD*YLTD*R-BBRM-resin 
7 SL11(Y4F) 2-PBA-RLD*FLTD*R-BBRM-resin 
8 SL11(T6Abu) 2-PBA-RLD*YLAbuD*R-BBRM-resin 
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lines. DU145 and PC3 cell lines are also used in the research. They are highly metastatic 
cell lines.8 
            RWPE_1, WPE_1NA22 and WPE_1NB14 cells were cultured in keratinocyte 
serum-free medium (K-SFM) with epidermal growth factor (EGF) and bovine pituitary 
extract (BPE). DU145 and PC3 cells were cultured in Rosewell Park Memorial Institute 
media (RPMI) with fetal bovine serum (FBS), sodium bicarbonate, antibiotics, L-
glutamine, D-glucose, HEPES, and sodium pyruvate. Cells were cultured to around 70% 
confluent and starved for 48 hours and then secreted proteins were collected from the 
media. The 300 um beads which contained SLs were washed with PBS, and pre-blocked 
with 1% BSA in PBS with glycerol and then incubated with 0.0002 mg/ml FITC labeled 
secreted proteins individually overnight. The beads were then washed with PBS three 
times and imaged under a microscope using a green fluorescent protein (GFP) filter set. 
Matlab was used to extract the brightness of the beads. The brightness indicates the 
binding affinity of SLs with the proteins. 
            The results were shown in Figure 3.1. The data were normalized against the 
intensity of SL11. When the arginine was replaced to alanine, the binding affinities of SL 
with 5 kinds of proteins all decreased. This might be because the negatively charged 
glycans like the positively charged arginine. Therefore the replacement of arginine to 
alanine reduces the binding affinity. But the decreases are not significant, which indicates 
the negatively charged glycans are not abundant in prostate cell lines. Upon replaceing 
the tyrosine to phenylalanine, basically getting rid of an –OH, the binding affinities of SL 
with most of the proteins increased. But there was not a significant trend when the 
aromatic ring was gotten rid of based on the comparison between SL11 (T6Abu) with 
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SL11 (T6A) and SL11 (Y4F) with SL11 (Y4A). That indicates there might be some 
interactions between the glycans and the aromatic system. For most of the proteins, the 
replacement of leucine, a bulky group, increased the binding affinities. So in order to 
incur better binding affinity, leucine can be replaced.  There is no significant tendency 
when replace the threonine to alanine or amino butyric acid.  
            SL11 and its mutants were also used to classify cell lines. The classification 
matrix is shown in Table 3.2. The result showed that SL11 and its mutants could 
successfully classify 5 cell lines. The total classification accuracy was 96%. The 
jackknifed validation showed a similar result, with a total accuracy of 92%. This showed 
SLs’ great ability at classifying cell lines. There were two DU145 samples mistaken as 
PC3 and one WPE_1NA22 sample was misclassified as WPE_1NB14. There were also 
two WPE_1NB14 samples misclassified as DU145 and PC3. However, these 
misclassifications are understandable because WPE_1NA22 are close to WPE_1NB14 in 
metastatic potential and WPE_1 NB14 is close to highly metastatic cell lines by 
metastatic potential. The total classification accuracy was still decent and the healthy cell 
line was grouped very well. Since the 5 cell lines have different metastatic potential.  
            These cell lines were also classified by their metastatic potential. The 
classification matrix was shown in Table 3.3. Healthy cell line was grouped very well 
within its category. There were some misclassifications between lowly metastatic cell 
lines and highly metastatic cell lines. But the total classification accuracy was very decent 
at 95%. The jacknifed classification accuracy, which involves allocating each individual 
to its closest group without using it to determine the center of the group, was 94%.  The 2 
dimensional LDA plot was shown in Figure 3.2. Lowly metastatic samples overlapped 
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with highly metastatic samples a little bit. But generally speaking, they were grouped 
very well within their categories.  
 
 
 
Figure 3.1 Activity relationship of SL11 with cell secreted proteins.  
 
   
Table 3.2 Classification matrix of 5 cell lines. 
 
  RWPE_1 WPE_1NA22 WPE_1NB14 DU145 PC3 %correct 
RWPE_1 50 0 0 0 0 100 
WPE_1NA22 0 41 1 0 0 98 
WPE_1NB14 0 0 39 1 1 95 
DU145 0 0 4 38 2 86 
PC3 0 0 0 0 27 100 
   Total 50 41 44 39 30 96 
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  Table 3.3 Classification matrix of 5 cell lines grouped by metastatic potential. 
 
 
Healthy Cancerous-lo Cancerous-hi %correct 
Healthy 50 0 0 100 
Cancerous-lo 0 78 5 94 
Cancerous-hi 3 2 66 93 
Total 53 80 71 95 
 
 
 
 
Figure 3.2 Two-dimensional LDA plot for distinguishing 5 cell lines with different 
metastatic potential. 
  
Canonical Scores Plot
-6 -2 2 6
FACTOR(1)
-6
-2
2
6
F
A
C
T
O
R
(2
)
Healthy
Cancerous-lo
Cancerous-hi
VAR00001
 38 
 
3.4   USE SL ARRAY TO CLASSIFY DIFFERENT CELL LINES 
            Previously, SL array which contains SL1 to SL9 on 300 um beads has been used 
to discriminate cell lines within each category of prostate, colon, and breast.  A 
microscope was used as a way to gain the binding information. This is a useful way to 
know the relative binding affinity and selectivity but in the mean time, it’s an energy-
consuming process, because the imaging process is a long process. Recently, flow 
cytometry has gained our attention. Flow cytometry measures multiple characteristics of 
individual particles flowing in single file in a stream of fluid. Light scattering at different 
angles can distinguish differences in size and internal complexity.9 The fluorescent 
intensity of the beads is quantified on a flow cytometer equipped with a 488 nm 
excitation source.  It is similar to a microscope to produce an image of the bead, but it 
offers "high-throughput" automated quantification of set parameters. So it can analyze a 
large quantity of beads in a short period of time, which saves the trouble from 
microscope. 
             The SLs used were SL1-SL9. They were coupled on 10 um polystyrene beads. 
RWPE_1, WPE_1NA22, WPE_1NB14, DU145, PC3, HTC116 and HT29 cell lines were 
used to study the ability of array to classify different cell lines.  The proteins were 
secreted proteins, which were isolated from the media. RWPE_1 is an epithelial cell line 
from a white male donor that was immortalized with HPV virus and it is a healthy cell 
line, which is not invasive10. Neoplastic cells WPE1_NA22 and WPE1_NB14 derived 
from RWPE-1 were used 11. Prostate cancer cell lines DU145 and PC3 cell lines were 
also used in the research. They are highly metastatic cell lines.  HCT116 and HT29 are 2 
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cancerous colon cell lines. They were used to study the ability of SL array to classify cell 
lines.  
            RWPE_1, WPE_1NA22 and WPE_1NB14 cells were cultured in K-SFM with 
EGF and BPE. DU145 and PC3 cells were cultured in RPMI media with FBS, Sodium 
Bicarbonate, antibiotics, L-glutamine, D-glucose, HEPES, and sodium pyruvate. HCT116 
and HT29 were cultured by my lab-mate Tanya Hundal. All the cells were cultured to 
around 70% confluent and starved for 48 hours and then secreted proteins were collected 
from the media and precipitated with acetone. 
            Approximately 1 mg of the 10 μm polystyrene beads which contain SLs were 
transferred to Eppendorf tubes each and washed with PBS, and pre-blocked with 1mL of 
PBS with 10% glycerol (v/v) and 2% BSA (w/v) (blocking buffer). Diluted the FITC 
labeled glycoprotein sample to 0.0002 mg/mL in PBS with 2% BSA and 2% EtOH and 
then added 1 ml of the protein solution in each Eppendorf tube contained beads and 
incubated individually for 12 hours. The beads were then washed with 1 ml PBS with 2% 
BSA and 2% EtOH 3 times and resuspended the beads in 1 ml of PBS with 2% BSA and 
2% EtOH. Finally, apply the Flowmi 40μm to the end of the 1 mL pipet tip, and filter to 
sample through the strainer into a clean 1.5 mL Eppendorf tube. The fluorescence 
informations of the sample were quantified by flow cytometer within three hours, which 
should take around 7-9 hours using microscope. Using LDA analysis, seven cell lines 
were successfully classified with a classification accuracy of 88%. Table 3.4 shows the 
cross validation which was used to quantitatively measure the classification accuracy. 
The jackknifed classification accuracy was also 88%.  
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  Table 3.4 Classification matrix of 7 cell lines. 
 
  
RWEP_1 
WPE_1 
NA22 
WPE_1 
NB14 
DU145 PC3 HCT116 HT29 %correct 
RWEP_1 162 7 0 0 46 3 5 73 
WPE_1 
NA22 
6 211 0 0 8 0 6 91 
WPE_1 
NB14 
0 0 226 0 0 0 0 100 
DU145 0 0 0 197 0 0 0 100 
PC3 43 4 0 0 169 2 9 74 
HCT116 14 1 0 0 6 198 4 89 
HT29 9 4 0 0 8 1 206 90 
Total 234 227 226 197 237 204 230 88 
 
 
 
            According to the classification matrix, DU145 and WPE_1NB14 grouped very 
well within their categories with 100% classification accuracy. The most misclassified 2 
cell lines were PC3 and RWPE_1. It seemed the SL array, which contained SL1-SL9 
didn’t classify these 2 cell lines very well. This result has a great difference from the 
previous study with SL11 and mutants. SL11 and it mutants classified PC3 and RWPE_1 
very well. There is no misclassification between these 2 cell lines. That could indicate 
SL11 and its mutants have better ability to discriminate PC3 cell line and RWPE_1 cell 
line. So in further study, some SLs in SL11 and its mutants can be added to the array to 
see if they can help better discriminate this two cell lines. It’s very likely that they can 
help with the discriminant because SL11 is chosen against PC3 out of the dual dye 
competitive assay of PC3 and RWPE_1. Therefore, it’s likely to bind to some 
glycoproteins only existing in PC3 but not in RWPE_1. So the binding signals for PC3 
and RWPE_1 with SL11 or its mutants should be different.  
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3.5 CONCLUSIONS AND OUTLOOK 
            The 300um tentagel beads have shown to have a very good ability to discriminate 
cell lines. But the imaging process is a time-consuming process.  Now we are trying to 
use 10um polystyrene beads, because the fluorescent intensity information of these small 
beads can be gained by flow cytometry, which is a "high-throughput" method that can get 
the information much faster. The SLs on smaller polystyrene beads are also good at 
discriminate cell lines with a classification accuracy of 88%.  
            Synthetic lectins have a great ability at classifying cell lines with different 
metastatic potential.  Even just SL11 and its mutants are good to classify cell lines, with a 
classification accuracy of 96%. However, the structure-activity relationships of SL11 
with glycoproteins are not easy to fully understand. Positively charged arginine may help 
with the binding, but the influence is not huge. It’s possible that different portions of SLs 
and proteins work together to have the binding affinity instead of a single piece. So 
changing only one piece of SL11 does not incur a significant difference in binding. 
Further study need to be done to have a better understanding of the binding mechanistics. 
3.6 EXPERIMENTAL METHODS 
Chemicals  
All amino acids and O-Benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-
phosphate (HBTU) were purchased from Novabiochem Corp. Polystyrene M NH2 (Cat. 
No. RTH-9940-PI) was purchased from Peptides International. TentaGel resin (Cat. No. 
MB-300-002; loading level 0.25-0.3 mmol/g) was purchased from Rapp Polymere. 
Glycoproteins and FITC were purchased from Sigma-Aldrich.  
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Microscope Usage  
A Leica MZ 16F microscope and a GFP filter set (excitation 450-490 nm; emission filter 
500-550 nm) were used to take images, which were analyzed by Adobe Photoshop to 
obtain luminosity values afterwards. The luminosity values, which indicate the 
fluorescent intensity of the beads tell us the binding intensity. High average luminosity 
values means brighter beads, which correspond to strong binders.  
General Method for Synthetic Lectin Synthesis 
All of the SLs used started with the same first four amino acids, BBRM, before 
introducing other amino acids. For SL1-SL9, acylated arginine was used to cap the ends. 
For SL11 and its series mutants, no acylation was used. 2-Formylphenylboronic acid was 
incorporated onto Diamino-butyric acid, which is a non-natural amino acid. For SL11 and 
its mutants, there’s also one 2-Formylphenylboronic acid one the first arginine. Standard 
Fmoc/HBTU chemistry was used to extend the peptide backbone. The amino acids had 
Fmoc protected amines. Reactive side chains of the amino acids were protected by acid-
labile protecting groups. The beads were first soaked in DMF for 10 mins, and pre-
activated amino acid was added. After tumbling 1 h, the beads were washed with DMF, 
methanol and DMF. To remove the Fmoc group, 10 mL 20% piperidine in DMF was 
used. The next amino acid was coupled using the same procedure.  
Synthesis of SL11 and Its Mutants 
TentaGel resin (300 µM; loading capacity 0.25 mmol/g) was used to synthesize SL 11 
mutants. After the peptide was synthesized, the N-terminus was not acylated. The ivDde 
protecting group of the side-chain amine on Dab was selectively removed by 5% 
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hydrazine in DMF for 1 h for 3 times. Then, 2-formylphenylboronic acid was 
incorporated. 
Incorporation of Phenyl Boronic Acid 
The diamino acid ivDde protecting group was removed with 10 mL of 5% (v/v) 
hydrazine monohydrate in DMF for 3 times. 8 equivalent of 2-Formylphenyl boronic acid 
was dissolved in a mixture of 0.2 mL methanol and 9.8 mL DMF and the liquid was 
added to the beads along with  activated 3Ǻ molecular sieves and tumbled at 37 ºC 
overnight.  NaBH4 was added and the cap was open for around 0.5 h to let the gas release 
and the resin was tumbled at 37 ºC for 4 h, followed by washing with DMF, methanol, 
and DMF. Molecular sieves were removed by adding DCM so the beads would flow 
while the molecular sieves were still at the bottom. So the beads can be transferred to 
another reaction vessel.  After the boronic acid moiety was coupled, 10 mL of 95% TFA, 
2.5% water, and 2.5% triisopropysilane was added and the resin was tumbled for 1 h to 
deprotect the acid-labile protecting groups. The resin was then washed with DMF, 
methanol, and DMF. 
Phosphate Buffered Saline (PBS)  
Sodium phosphate monobasic (monohydrate) (27.6 g, 200 mmol), sodium phosphate 
dibasic (anhydrous) (28.4 g, 200 mmol) and sodium chloride (35.06 g, 600 mmol) were 
dissolved in 4 L of DI water and the pH was adjusted to 7.2-7.3 using 3 M NaOH.  
Cell Culture 
All supplements and media for RWPE_1, WPE_1NA22, WPE_1NB14, DU145, PC3, 
HTC116 and HT29 cell lines were ordered.  RWPE_1, WPE_1NA22 and WPE_1NB14 
cells were cultured in K-SFM with EGF and BPE. DU145 and PC3 cells were cultured in 
 44 
 
RPMI media with carbonate buffer, antibiotics, glutamine, HEPES, and carbonate 
pyruvate. HCT116 and HT29 were cultured by my lab-mate Tanya Hundal. The cells 
were grown in T75 flasks at 370C. Complete growth medium was pre-warmed by placing 
into a warm incubator before using. Complete growth medium was stored at 40C when 
not using. 
Secreted Protein Preparation  
Cells were starved 48 hours before collecting the secreted proteins. After starvation, 
media was collected and spun to remove any cells or cell debris. Then a 3 kDa spun tube 
was used to filter the media in order to filter out anything smaller than 3 kDa. PBS was 
used twice to wash so the proteins were in PBS.  Cold acetone was used to precipitate 
proteins in the media. The proteins were then washed with acetone one more time and air 
dry to get the solid after the removal of excess acetone. 
Binding Studies of SLs on Tentagel Resins with Secreted Protein  
2mg of each SL was weighed into a centrifuge tube.  The SLs were then rinsed with PBS 
for 10 minutes for twice. The PBS was removed and 1%BSA in PBS with 10% glycerol 
was put in the tubes and incubated for 15 minutes in order to remove non-specific 
binding.   The solution was then removed. 0.0002mg/ml secreted proteins were added to 
the SLs and then tumbled for 6 hours at room temperature under aluminum foil.  After 
tumbling the beads were washed three times with PBS and imaged with a fluorescence 
microscope, Leica MZ 16F, using a GFP filter set. 
Binding Studies of SLs on Polystyrene Beads with Secreted Protein  
Approximately 1 mg of the 10μm polystyrene beads which contain SL1 to SL9 were 
transferred to Eppendorf tubes each and washed with PBS twice, and pre-blocked with 
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1mL of PBS with 10% glycerol (v/v) and 2% BSA (w/v) (blocking buffer). Diluted the 
FITC labeled glycoprotein sample to 0.0002 mg/mL in PBS with 2% BSA and 2% EtOH 
and then added 1 ml of the diluted protein solution in each Eppendorf tube contained 
beads and incubated individually for 12 hours. The beads were then washed with 1 ml 
PBS with 2% BSA and 2% EtOH 3 times and resuspended the beads in 1 ml of PBS with 
2% BSA and 2% EtOH. Finally, applied the Flowmi 40μm to the end of the 1mL pipet 
tip, and filtered to sample through the strainer into a clean 1.5mL Eppendorf tube. The 
fluorescence information of the sample were quantified by flow cytometry. 
3.7 REFERENCES 
1. Bertozzi, C. R.; Dube, D. H.,Glycans in cancer and inflammation. Potential for 
therapeutics and diagnostics. Nat. Rev. Drug Discov. 2005, 4, 477-488. 
2. Foster, M. M.; Brown, J. R.; Wang, L. C.; Esko, J. D., A disaccharide precursor of 
sialyl Lewis X inhibits metastatic potential of tumor cells. Cancer Research 2003, 63, 
2775-2781. 
3. Ogawa, J.; Sano, A.; Koide, S.; Shohtsu, A., Relation between Recurrence and 
Expression of Proliferating Cell Nuclear Antigen, Sialyl Lewis(X), and Sialyl Lewis(a) in 
Lung-Cancer. J. Thorac, Cardiovasc. Surg. 1994, 108, 329-336. 
4. Nakamori, S.; Kameyama, M.; Imaoka, S.; Furukawa, H.; Ishikawa, O.; Sasaki, Y.; 
Izumi, Y.; Irimura, T., Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal 
cancer metastasis. Dis. Colon and Rectum. 1997, 40, 420-431. 
5. Cancer Facts & Figures. American Cancer Society 2015. Available online: 
http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2015/ 
6. Bello, D.; Webber, M. M.; Kleinman, H. K.; Wartinger, D. D.; Rhim, J. S., Androgen 
responsive adult human prostatic epithelial cell lines immortalized by human 
papillomavirus 18. Carcinogenesis 1997, 18, 1215–1223. 
7  Nambiar, D. K.; Deep, G.; Singh, R. P.; Agarwal, C.; Agarwal, R., Silibinin inhibits 
aberrant lipid metabolism, proliferation and emergence of androgen-independence in 
prostate cancer cells via primarily targeting the sterol response element binding protein. 
Oncotarget 2014, 5, 10017–10033. 
8. Bello, D.; Webber, M. M.; Kleinman, H. K.; Wartinger, D. D.; Rhim, J. S., Androgen 
responsive adult human prostatic epithelial cell lines immortalized by human 
papillomavirus 18. Carcinogenesis 1997, 18, 1215–1223. 
9. Brown, M.; Wittwer, C., Flow Cytometry: Principles and Clinical Applications in 
Hematology. Clinical Chemistry 2000, 46, 1221–1229. 
10. Bello, D.; Webber, M. M.; Kleinman, H. K.; Wartinger, D. D.; Rhim, J. S., Androgen 
responsive adult human prostatic epithelial cell lines immortalized by human 
papillomavirus 18. Carcinogenesis 1997, 18, 1215–1223. 
 46 
 
11. Nambiar, D. K.; Deep, G.; Singh, R. P.; Agarwal, C.; Agarwal, R., Silibinin inhibits 
aberrant lipid metabolism, proliferation and emergence of androgen-independence in 
prostate cancer cells via primarily targeting the sterol response element binding protein. 
Oncotarget 2014, 5, 10017–10033. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 47 
 
CHAPTER 4 
CONCLUSIONS AND FUTURE WORK 
4.0 SUMMARY OF WORK 
            Prostate cancer is now the second leading cause of cancer death in American men 
according to American Cancer Society. There have been diagnostics for prostate cancer. 
Main methods include PSA (Prostate specific antigen) blood test, digital rectal exam, 
biopsy, etc.1 However, these diagnostics are not perfect. For instance, biopsy is a painful 
process for patients and may cause bleeding and infection. So a new prostate cancer 
diagnostic is in great need. Glycosylation patterns can provide information about diease.2 
Glycans and glycoproteins on the cell surface will be over, under or neo-expressed when 
the cancer occurs.3 Different cancer types may have different glycosylation pattern. 
Therefore the different glycosylation patterns can be used for cancer diagnosis.4-6 In order 
to study and use these glycosylation patterns, a synthetic lectin array has been developed. 
Synthetic lectin array contains 9 SLs and have showed great ability to classify cell lines.  
            Synthetic lectins use the boronic acid-diol interaction, which is a kind of covalent 
yet reversible interaction. They have many advantages like non-toxic, low cost and stable.
The design of synthetic lectins also guarantee the diversity of the synthetic lectins since 
there are many kinds of natural or non-natural amino acid that we can use. This thesis 
focused on the structure-activity relationships of SL11 with purified glycoproteins, cell 
membrane proteins and secreted proteins. It’s interesting that the replacement of arginine 
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to alanine can decrease the binding affinity no matter what kind of proteins used. That is 
likely due to the negatively charged glycan moieties on the glycoprotein like to interact 
with positively charged arginines. Therefore arginine can help increase the binding 
affinity. However, charge does not hugely influence the binding affinity with prostate cell 
proteins compared with purified glycoproteins. This might indicate that the negatively 
charged glycans are not so abundant in prostate cell lines compared with purified 
glycoproteins. But positively charged arginine is more important in the binding of SL 
with highly metastatic cell lines compared with lowly metastatic cell lines or healthy cell 
lines. That indicates there might be an over-expression of sialic acid group in highly 
metastatic cell lines.  
             The 300 um beads have shown to have a very good ability to discriminant cell 
lines. But the imaging process is a time-consuming process.  Recently, 10 um beads and 
flow cytometry have caught our eyes. Flow cytometry method measures multiple 
characteristics of individual particles flowing in single file in a stream of fluid. Light 
scattering at different angles can distinguish differences in size and internal complexity.7  
The fluorescent intensities of the beads are quantified on a flow cytometer equipped with 
a 488 nm excitation source. It offers "high-throughput" automated quantification of set 
parameter so that can get the information so much faster. The incubation of SL array on 
smaller polystyrene beads with 7 cell lines was done. The 7 cell lines used were HCT116, 
HT29, RWPE-1, WPE_1NA22, WPE_1NB14, DU145, and PC3.  The SLs on 
polystyrene beads discriminated 7 cell lines with a classification accuracy of 88%. The 
cell lines that were most misclassified were PC3 and RWPE_1 cell lines. Using SL11 and 
its mutants had a classification accuracy of 96% in classifying 5 prostate cell lines.  PC3 
 49 
 
and RWPE_1 were not misclassified with each other. So in the near future, SL11 can be 
added in the SL array in order to increase the classification accuracy. 
4.1 THE FUTURE OF SL SENSOR ARRAYS 
            The mechanistic details of the SL-protein binding are still not clearly figured out. 
But it’s very possible that positive charge can help increase the binding affinity between 
SL and negatively charged glycans. So in further study, more charged amino acid point 
mutations need to be done to get SLs that have better binding affinity with glycoproteins 
and better discriminant of cell lines. With the help of flow cytometry, this study can be 
done much faster. 
          The SL array has been used to classify many cell lines. Since we have tried to use 
10um beads and flow cytometry to classify cell lines, we need to compare the data from 
flow cytometry with the data from microscope to make sure they are consistent with each 
other. Also, more cell lines need to be tested.   
             It’s advantageous to use secreted proteins instead of membrane proteins because 
of the ease and cheaper price in collecting secreted proteins. Secreted proteins can better 
represent the protein in blood while membrane proteins are more like proteins in tissue. If 
there will be a more accurate diagnostic using blood, it will reduce a lot of pains and 
trouble doing prostate biopsy to patients. Since flow cytometry has been used, we can 
also try to do the whole cell screening. So in further study, the SLs can be cleaved from 
the beads and incubate with cells individually. By screening the whole cells, we can still 
get a pattern from the SL array. Since there will be more information on cells compared 
with membrane or secreted proteins, it’s also a good alternative to screen the whole cells. 
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           It’s not necessary to always use SL1-SL 9 as the synthetic lectin array. Some SLs 
in the array may have great binding affinity with many cell proteins. Therefore they are 
not capable of helping classify different cell lines. So we can exclude some of them from 
the array.  We have begun to choose SLs against cell lines. In the future, we can 
gradually choose more interesting SLs from the screening of SL library incubated with 
cell proteins instead of purified glycoproteins. As we find more interesting SLs, we can 
also add them in the array, in order to get better classification accuracy. As we do more 
research, we can gradually use more human tissues or blood instead of just using cell 
lines. 
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